The 9p21 Genotype and Risk for Cardiovascular Disease
Dosage of an at-risk variant appears to increase the risk for severe coronary artery disease, but the clinical implications of the genotype remain unclear.
Welcome to Journal Watch. The content you requested requires sign in with a username and password.
Sign In
Sign Up
Print subscribers
Activate your free online account for full access to all site content and features.
Other visitors
Subscribe for full access to all site content and features. ($99/year)
Purchase a site pass for full access to all articles. ($19/7 days)
Or, simply register for free access to email alerts, site features, and article archives. (FREE)
